On average, people taking Zepbound lost about 50 pounds, while those taking Wegovy dropped about 33 pounds. The participants were given a maximum tolerated dose of either Zepbound or Wegovy.

With more people taking the weight-loss drugs Wegovy and Zepbound, one question inevitably arises: which one is more effective? In a press release, Lilly announced that in its latest trial ...

Alongside this initiative, Multazim introduces The Multi Dose Podcast, a platform featuring insightful conversations with thought leaders and experts across various fields. A New Standard in Media ...

Later, Wegovy, a higher-dose version of semaglutide, was approved in 2021 specifically for weight management in individuals with obesity or those who are overweight with related health conditions.

Last month, Novo launched Wegovy in China, the world's second-largest pharmaceuticals market, pricing a month's supply of the starter dose at 1,400 yuan ($193.27), far lower than its U.S. list ...

Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly. In a head-to-head comparison of the two GLP-1 drugs ...

Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in the first large, head-to-head trial of the highly in ...

The weight loss revolution is in full swing, with the number of patients receiving Wegovy (NVO) having doubled while those receiving Zepbound have tripled since January 2024. While demand is ...

Taking Wegovy (semaglutide) can be a powerful step towards achieving weight loss goals and improving overall health—especially when done in conjunction with lifestyle changes, such as following ...

Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from ...